Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infection.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Vaccine

• Publication date

  2008-06-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2008.03.100PMID 18486283PMCID PMC2577850
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes

  2007cited by this paper
• Mamu-B*08-Positive Macaques Control Simian Immunodeficiency Virus Replication

  2007cited by this paper
• The Major Histocompatibility Complex Class II Alleles Mamu-DRB1*1003 and -DRB1*0306 Are Enriched in a Cohort of Simian Immunodeficiency Virus-Infected Rhesus Macaque Elite Controllers

  2007cited by this paper
• Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1

  2007cited by this paper
• Comprehensive characterization of MHC class II haplotypes in Mauritian cynomolgus macaques

  2007cited by this paper
• Identification of MHC class I sequences in Chinese-origin rhesus macaques

  2007cited by this paper
• A Replication-Competent Adenovirus-Human Immunodeficiency Virus (Ad-HIV) tat and Ad-HIV env Priming/Tat and Envelope Protein Boosting Regimen Elicits Enhanced Protective Efficacy against Simian/Human Immunodeficiency Virus SHIV89.6P Challenge in Rhesus Macaques

  2007cited by this paper
• Improved Vaccine Protection from Simian AIDS by the Addition of Nonstructural Simian Immunodeficiency Virus Genes1

  2006cited by this paper
• An Adenovirus-Based HIV Subtype B Prime/Boost Vaccine Regimen Elicits Antibodies Mediating Broad Antibody-Dependent Cellular Cytotoxicity Against Non-Subtype B HIV Strains

  2006cited by this paper
• Control of Simian Immunodeficiency Virus SIVmac239 Is Not Predicted by Inheritance of Mamu-B*17-Containing Haplotypes

  2006cited by this paper
• The High-Frequency Major Histocompatibility Complex Class I Allele Mamu-B*17 Is Associated with Control of Simian Immunodeficiency Virus SIVmac239 Replication

  2006cited by this paper
• Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses.

  2006cited by this paper
• Simian Immunodeficiency Virus SIVmac239 Infection of Major Histocompatibility Complex-Identical Cynomolgus Macaques from Mauritius

  2006cited by this paper
• Cutting Edge: Resistance to HIV-1 Infection among African Female Sex Workers Is Associated with Inhibitory KIR in the Absence of Their HLA Ligands1

  2006cited by this paper
• KIR/HLA Pleiotropism: Protection against Both HIV and Opportunistic Infections

  2006cited by this paper
• Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag.

  2005cited by this paper
• Replicating Rather than Nonreplicating Adenovirus-Human Immunodeficiency Virus Recombinant Vaccines Are Better at Eliciting Potent Cellular Immunity and Priming High-Titer Antibodies

  2005cited by this paper
• Unusually High Frequency MHC Class I Alleles in Mauritian Origin Cynomolgus Macaques

  2005cited by this paper
• Pathogenicity of Simian-Human Immunodeficiency Virus SHIV-89.6P and SIVmac Is Attenuated in Cynomolgus Macaques and Associated with Early T-Lymphocyte Responses

  2005cited by this paper
• Monitoring of human immunological responses to vaccinia virus.

  2004cited by this paper
• Protection against Mucosal Simian Immunodeficiency Virus SIVmac251 Challenge by Using Replicating Adenovirus-SIV Multigene Vaccine Priming and Subunit Boosting

  2004cited by this paper
• A call for replicating vector prime-protein boost strategies in HIV vaccine design

  2004cited by this paper
• Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA

  2004cited by this paper
• Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys.

  2004cited by this paper
• Expression of the Major Histocompatibility Complex Class I Molecule Mamu-A*01 Is Associated with Control of Simian Immunodeficiency Virus SIVmac239 Replication

  2003cited by this paper
• Potent, Persistent Induction and Modulation of Cellular Immune Responses in Rhesus Macaques Primed with Ad5hr-Simian Immunodeficiency Virus (SIV) env/rev, gag, and/or nef Vaccines and Boosted with SIV gp120

  2003cited by this paper
• Major Histocompatibility Complex Class I Alleles Associated with Slow Simian Immunodeficiency Virus Disease Progression Bind Epitopes Recognized by Dominant Acute-Phase Cytotoxic-T-Lymphocyte Responses

  2003cited by this paper
• The influence of HLA genotype on AIDS.

  2003cited by this paper
• Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS

  2002cited by this paper
• Mamu-A*01 Allele-Mediated Attenuation of Disease Progression in Simian-Human Immunodeficiency Virus Infection

  2002cited by this paper
• Tat-Vaccinated Macaques Do Not Control Simian Immunodeficiency Virus SIVmac239 Replication

  2002cited by this paper
• ALVAC-SIV-gag-pol-env-Based Vaccination and Macaque Major Histocompatibility Complex Class I (A*01) Delay Simian Immunodeficiency Virus SIVmac-Induced Immunodeficiency

  2002cited by this paper
• Outcome of Simian-Human Immunodeficiency Virus Strain 89.6p Challenge following Vaccination of Rhesus Macaques with Human Immunodeficiency Virus Tat Protein

  2002cited by this paper
• Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P).

  2001cited by this paper
• The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals.

  2001cited by this paper
• HIV-1 Tat vaccines.

  2001cited by this paper
• Antibodies against full-length Tat protein and some low-molecular-weight Tat-peptides correlate with low or undetectable viral load in HIV-1 seropositive patients.

  2001cited by this paper
• Minimization of chronic plasma viremia in rhesus macaques immunized with synthetic HIV-1 Tat peptides and infected with a chimeric simian/human immunodeficiency virus (SHIV33).

  2000cited by this paper
• Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology.

  2000cited by this paper
• Vaccination with Tat toxoid attenuates disease in simian/HIV-challenged macaques

  2000cited by this paper
• Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques.

  2000cited by this paper
• SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine

  2000cited by this paper
• Extracellular HIV-1 tat protein up-regulates the expression of surface CXC-chemokine receptor 4 in resting CD4+ T cells.

  1999cited by this paper
• Vaccination with Rev and Tat against AIDS.

  1999cited by this paper
• Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine

  1999cited by this paper
• Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine.

  1998cited by this paper
• Tat Protein Induces Human Immunodeficiency Virus Type 1 (HIV-1) Coreceptors and Promotes Infection with both Macrophage-Tropic and T-Lymphotropic HIV-1 Strains

  1998cited by this paper
• An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge

  1997cited by this paper
• HIV‐1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix‐associated heparan sulfate proteoglycans through its basic region

  1997cited by this paper
• Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS.

  1997cited by this paper
• A recombinant prime, peptide boost vaccination strategy can focus the immune response on to more than one epitope even though these may not be immunodominant in the complex immunogen.

  1997cited by this paper
• Tat protein induces self-perpetuating permissivity for productive HIV-1 infection.

  1997cited by this paper
• Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes

  1996cited by this paper
• HIV–1 Tat protein as a potential AIDS vaccine

  1996cited by this paper
• A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys

  1996cited by this paper
• Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein.

  1995cited by this paper
• Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma

  1994cited by this paper
• Block of HIV-1 infection by a combination of antisense tat RNA and TAR decoys: a strategy for control of HIV-1.

  1994cited by this paper
• Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis.

  1993cited by this paper
• Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation

  1993cited by this paper
• Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

  1990cited by this paper
• Cellular uptake of the tat protein from human immunodeficiency virus.

  1988cited by this paper
• The trans-activator gene of the human T cell lymphotropic virus type III is required for replication.

  1986cited by this paper
• The trans-activator gene of HTLV-III is essential for virus replication

  1986cited by this paper
• Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

  1985cited by this paper

• Functional differences and similarities in activated peripheral blood mononuclear cells by lipopolysaccharide or phytohemagglutinin stimulation between human and cynomolgus monkeys

  2021cites this paper
• Inter- and intrabreed diversity of the major histocompatibility complex (MHC) in primitive and draft horse breeds

  2020cites this paper
• The Cynomolgus Macaque MHC Polymorphism in Experimental Medicine

  2019cites this paper
• Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques

  2018cites this paper
• An aerosol challenge model of tuberculosis in Mauritian cynomolgus macaques

  2017cites this paper
• Comprehensive identification of high-frequency and combination MHC-DMA and -DMB alleles in a cohort of Chinese rhesus macaques and cynomolgus macaques of Vietnamese origin.

  2015cites this paper
• B-Cells and the Use of Non-Human Primates for Evaluation of HIV Vaccine Candidates.

  2015cites this paper
• Genome typing of nonhuman primate models: implications for biomedical research.

  2014cites this paper
• Long-Term Central and Effector SHIV-Specific Memory T Cell Responses Elicited after a Single Immunization with a Novel Lentivector DNA Vaccine

  2014cites this paper
• Condylomatous Genital Lesions in Cynomolgus Macaques from Mauritius

  2013cites this paper
• Differential Response of the Cynomolgus Macaque Gut Microbiota to Shigella Infection

  2013cites this paper
• Comprehensive identification of high-frequency and co-occurring Mafa-DPA1, Mafa-DQA1, Mafa-DRA, and Mafa-DOA alleles in Vietnamese cynomolgus macaques

  2013cites this paper
• 51 – Human immunodeficiency virus vaccines

  2013cites this paper
• Comprehensive identification of high-frequency and co-occurring Mafa-B, Mafa-DQB1, and Mafa-DRB alleles in cynomolgus macaques of Vietnamese origin

  2012cites this paper
• Influence of MHC class I and II haplotypes on the experimental infection of Mauritian cynomolgus macaques with SHIVSF162P4cy.

  2012cites this paper
• Characterisation of MHC haplotypes in a breeding colony of Indonesian cynomolgus macaques reveals a high level of diversity

  2012cites this paper
• A summary of meeting proceedings for ‘Measuring immune responses in non-human primates for drug development—Opportunities and challenges for predicting human efficacy and immunotoxicity’

  2012cites this paper
• Characterization of the major histocompatibility complex class I A alleles in cynomolgus macaques of Vietnamese origin.

  2012cites this paper
• NK and CD4+ T Cell Cooperative Immune Responses Correlate with Control of Disease in a Macaque Simian Immunodeficiency Virus Infection Model

  2012cites this paper
• Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review.

  2011cites this paper
• Early Potent Protection against Heterologous SIVsmE660 Challenge Following Live Attenuated SIV Vaccination in Mauritian Cynomolgus Macaques

  2011cites this paper
• A combination HIV vaccine based on Tat and Env proteins was immunogenic and protected macaques from mucosal SHIV challenge in a pilot study.

  2011cites this paper
• Diversity of TRIM5α and TRIMCyp sequences in cynomolgus macaques from different geographical origins

  2011cites this paper
• Influence of the MHC genotype on the progression of experimental SIV infection in the Mauritian cynomolgus macaque

  2011cites this paper
• Mhc haplotype M3 is associated with early control of SHIVsbg infection in Mauritian cynomolgus macaques.

  2010cites this paper
• Study of cynomolgus monkey (Macaca fascicularis) DRA polymorphism in four populations

  2010influential citation
• Characterization of the major histocompatibility complex class II DOB, DPB1, and DQB1 alleles in cynomolgus macaques of Vietnamese origin

  2010cites this paper
• Impact of Viral Dose and Major Histocompatibility Complex Class IB Haplotype on Viral Outcome in Mauritian Cynomolgus Monkeys Vaccinated with Tat upon Challenge with Simian/Human Immunodeficiency Virus SHIV89.6P

  2010cites this paper
• MHC Heterozygote Advantage in Simian Immunodeficiency Virus–Infected Mauritian Cynomolgus Macaques

  2010cites this paper
• Lentiviral Vector-Based Prime/Boost Vaccination against AIDS: Pilot Study Shows Protection against Simian Immunodeficiency Virus SIVmac251 Challenge in Macaques

  2009cites this paper
• HIV-1 Tat-Based Vaccines: An Overview and Perspectives in the Field of HIV/AIDS Vaccine Development

  2009cites this paper
• Characterization of 47 MHC class I sequences in Filipino cynomolgus macaques

  2009cites this paper
• Multi-Low-Dose Mucosal Simian Immunodeficiency Virus SIVmac239 Challenge of Cynomolgus Macaques Immunized with “Hyperattenuated” SIV Constructs

  2009cites this paper
• Mauritian Cynomolgus Macaques Share Two Exceptionally Common Major Histocompatibility Complex Class I Alleles That Restrict Simian Immunodeficiency Virus-Specific CD8+ T Cells

  2009cites this paper
• Mhc haplotype H6 is associated with sustained control of SIVmac251 infection in Mauritian cynomolgus macaques

  2009influential citation
• Identification of novel MHC class I sequences in pig-tailed macaques by amplicon pyrosequencing and full-length cDNA cloning and sequencing

  2009cites this paper
• MHC class I characterization of Indonesian cynomolgus macaques

  2008cites this paper
• The Mhc class II DRB genotype of Macaca fascicularis does not influence infection by simian retrovirus type 2.

  2008cites this paper
• Complete Characterization of Killer Ig-Like Receptor (KIR) Haplotypes in Mauritian Cynomolgus Macaques: Novel Insights into Nonhuman Primate KIR Gene Content and Organization1

  2008cites this paper